Use of Midazolam in Hong Kong

Allyson van de Pol根據公開資料要求衞生署披露資料

This request has been closed to new correspondence from the public body. Contact us if you think it ought be re-opened.

此索取資料要求的回應嚴重逾期。 據《公開資料守則》,不論任何情況,衞生署應已回覆要求。 (詳情). 你可以透過一下途徑作出投訴requesting an internal review.

Dear Department of Health,

May I please ask the following:

-Does Hong Kong hold a stock of Midazolam currently or has it ever held a stock in the last five years?
-If yes to the above, please advise on the quantity of Midazolam used in hospitals/ care homes (and any other institutions) month by month, over the last five years.

Thank you!

Yours faithfully,

Allyson van de Pol

I am out of the office until 08/12/2021.

For urgent matters, please contact Miss Jackie LAM, CO(Per)4 at 3107 2571 /
&DH/CO[Per]4.

Note: This is an automated response to your message "Freedom of Information
request - Use of Midazolam in Hong Kong" sent on 25.11.2021 03:50:07 PM.

This is the only notification you will receive while this person is away.

Dear Allyson van de Pol,
Code on Access to Information
Re:Application No. DO EC 2348/21
Our department has received your application for access to information as
per email below. Regarding your questions, our replies are as follows:

For Question 1, Hong Kong Department of Health holds stock of Midazolam
currently.

For Question 2, Department of Health does not have information on the
quantity of Midazolam used in hospitals/ care homes (and any other
institutions) month by month, over the last five years.  Pursuant to
paragraph 1.14 of the Code on Access to Information (the Code), it does
not oblige departments to acquire information not in their possession.  We
are unable to provide the relevant information as requested.  Subject to
your agreement, we shall direct your request to the Hospital Authority
which may have the requested information.  

You may contact the undersigned at 2961 8856 if you need further
assistance.  

Thank you for your attention.
(Mr Shawn HUI)
for Director of Health

顯示引用部分

Dear Department of Health,

Thank you very much.

If you could advise as much detailed information as you can about Midazolam usage, that would be very kind.

Many thanks

Yours faithfully,

Allyson van de Pol

Dear Allyson van de Pol,

Code on Access to Information
Re:Application No. DO EC 2348/21

Our department has received your application for access to information as
per email below.  Your application is now under processing.  According to
paragraph 1.16 of the Code on Access to Information, our department will
inform you of the latest progress of the case separately on or before
24.12.2021.  In the meantime, please contact me at 2961 8856 if you have
any enquiry.

(Mr. Shawn HUI)
for Director of Health

顯示引用部分

Dear Department of Health,

Thank You

Yours faithfully,

Allyson van de Pol

Dear Allyson van de Pol,
Code on Access to Information
Re:Application No. DO EC 2348/21

Our department has received your request for internal review under the
Code on Access to Information (the Code) dated 4 December 2021.  We have,
in accordance with the established procedures and guidelines, conducted an
internal review.  I am authorised to give a reply below.

As mentioned in the first reply dated 3 December 2021, Department of
Health (DH) does not have information on the quantity of Midazolam used in
hospitals/ care homes (and any other institutions) month by month, over
the last five years since they are not managed by DH. We only have
Midazolam Injection 5mg/ml stocked at clinic dispensaries operated under
our department. As at 30.11.2021, there were 141 ampoules of Midazolam
Injection 5mg/ml at our clinic dispensaries.  The monthly stock level
remains the same in 2021.  

If you think that the DH has failed to properly apply any provision of the
Code, you may complain to The Ombudsman.  The address of the Office of The
Ombudsman is –

30/F, China Merchants Tower
Shun Tak Centre
168-200 Connaught Road Central
Hong Kong

Telephone: 2629 0555
Fax: 2882 8149
Email: [email address]

Thank you for your attention.

(Ms Teresa HO)
for Director of Health
From:        Shawn PS HUI/DH/HKSARG
To:        Allyson van de Pol <[FOI #893 email]>
Date:        13/12/2021 17:22
Subject:        *Restricted: Fw: Internal review of Freedom of Information
request - Use of Midazolam in Hong Kong

--------------------------------------------------------------------------

Dear Allyson van de Pol,

Code on Access to Information
Re:Application No. DO EC 2348/21

Our department has received your application for access to information as
per email below.  Your application is now under processing.  According to
paragraph 1.16 of the Code on Access to Information, our department will
inform you of the latest progress of the case separately on or before
24.12.2021.  In the meantime, please contact me at 2961 8856 if you have
any enquiry.

(Mr. Shawn HUI)
for Director of Health

From:        Allyson van de Pol <[FOI #893 email]>
To:        FOI requests at Department of Health <[Department of Health request email]>
Date:        04/12/2021 11:54
Subject:        Internal review of Freedom of Information request - Use of
Midazolam in Hong Kong

--------------------------------------------------------------------------

Dear Department of Health,

Thank you very much.

If you could advise as much detailed information as you can about
Midazolam usage, that would be very kind.

Many thanks

Yours faithfully,

Allyson van de Pol

顯示引用部分